Found 21 matching trials
LUTATHERA Injection General Use Result Survey
N/AThis study was a multicenter observational study with a central registratio...
Location
Novartis Investigative Site
Randomized Phase III of PRRT Versus Interferon
PHASE3The purpose of this study is to assess the benefit of 177Lu-DOTATATE versus...
Location
Jules Bordet Institute
Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
PHASE1Background:
A neuroendocrine tumor is a rare type of tumor. It comes from ...
Location
National Institutes of Health Clinical Center
Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor
NAMidgut neuroendocrine tumours present an increasing incidence and poor surv...
Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer
PHASE3DOTABREAST: Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTA...
Location
CHU Grenoble Alpes
Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients
PHASE2The purpose of the study is to evaluate efficacy and safety of Peptide Rece...
Location
Beijing Cancer Hospital
A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms
PHASE2This is a multicenter, single-arm, two-part study designed to evaluate the ...
Location
Fudan University Shanghai Cancer Center
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
PHASE1Background:
Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare diseas...
Location
National Institutes of Health Clinical Center
177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
PHASE3The purpose of this study is to determine if 68Gallium-octreotate and 18Flu...
Location
Jules Bordet Institute
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
N/AThe investigators will study SPECT imaging of radiopharmaceutical therapies...
Location
Johns Hopkins University